14 results
PRE 14A
IMPLQ
Impel Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:11pm
THE MEETING
GENERAL PROXY INFORMATION
CORPORATE GOVERNANCE STANDARDS AND DIRECTOR INDEPENDENCE
PROPOSAL NO. 1 - ELECTION OF CLASS II DIRECTORS
PROPOSAL NO. 2 … AND DIRECTOR INDEPENDENCE
We are committed to good corporate governance practices. These practices provide an important framework within which our Board
10-K/A
2022 FY
EX-3.2
IMPLQ
Impel Pharmaceuticals Inc
31 Mar 23
Annual report (amended)
4:21pm
or otherwise pursuant to this Section 1.12 and to serving as a director if elected;
(vii) whether such person meets the independence requirements of the stock … the eligibility of such proposed nominee to serve as a director of the Corporation and to determine the independence of such director under the Exchange Act
DEF 14A
IMPLQ
Impel Pharmaceuticals Inc
26 Apr 22
Definitive proxy
4:16pm
AND DIRECTOR INDEPENDENCE
PROPOSAL NO. 1 ELECTION OF CLASS I DIRECTORS
PROPOSAL NO. 2 RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
REPORT … and no requirement to have non-binding advisory votes on executive compensation.
CORPORATE GOVERNANCE STANDARDS AND DIRECTOR INDEPENDENCE
We are committed to good
10-K
2021 FY
IMPLQ
Impel Pharmaceuticals Inc
29 Mar 22
Annual report
5:09pm
ended December 31, 2021.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required by this Item
424B4
uy88q
10 Sep 21
Prospectus supplement with pricing info
4:01pm
DRS
cibc46vot h2
25 Aug 21
Draft registration statement
12:00am
10-Q
EX-3.2
po7jh
7 Jun 21
Quarterly report
7:17am
424B1
rzxxei6tggc0bk
23 Apr 21
Prospectus with pricing info
4:01pm
S-1
on0cci 6e
2 Apr 21
IPO registration
3:04pm
DRS/A
1mqqht1jsuowgbo06p
23 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next